Luminal Breast Cancer Cryoablation
Recruiting · NCT07447414 · Interventional (participants receive a specific treatment) · Lead sponsor: Lucía Graña López
View the official record on ClinicalTrials.gov →Interventions studied
Cryoablation with liquid nitrogen (Prosense® system)
What this trial is about
LUBRECA will evaluate the safety and efficacy of cryoablation with liquid nitrogen to treat cT1cN0 luminal breast cancer diagnosed in postmenopausal women
Who can take part
Age range
No age limits stated
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Postmenopausal women diagnosed with invasive breast cancer by core needle biopsy or vacuum-assisted biopsy
- Unifocal
- Lesion ≤ 2 cm (on ultrasound and contrast enhanced mammography)
- No axillary lymphadenopathy on ultrasound
- No axillary lymph node involvement on ultrasound.
- Luminal tumor (estrogen and/or progesterone receptor positive)
- HER2 negative
- Signed informed consent
Exclusion criteria
- Infiltrating lobular carcinoma
- Extensive in situ component
- Multifocality or multicentricity
- Contraindication for contrast mammography
- Not candidate for surgery
- Distant metastasis -
Where it is running
1 location listed.
- Hospital Universitario Lucus Augusti - Lugo, Lugo, Spain